INTRODUCTION
The adult peripheral nervous system (PNS) retains significant regenerative potential, enabling the repair of even severe injuries such as full transection of the nerve trunk (Chen et al., 2007) . Following a lesion to the nerve, the portion of the axons distal to the injury site degenerates. However, unlike central nervous system axons, damaged peripheral axons are able to regrow and reinnervate their targets (Chen et al., 2007) . This process is underpinned by the remarkable plasticity of the PNS glia, the Schwann cells (SCs) (Jessen et al., 2015; Kim et al., 2013a) . In intact nerves, SCs are present in two differentiated states, either myelinating large-caliber axons (myelinating SCs) or ensheathing groups of small-caliber axons in Remak bundles (nonmyelinating SCs) . In contrast, following injury, differentiated SCs reprogram to a progenitor-like cell. Dedifferentiated SCs switch off the myelination program and acquire an array of new phenotypes, which coordinately support nerve repair. These phenotypes include 1) secretion of neurotrophic factors to promote axonal survival, 2) clearance of myelin debris and expression of axonal guidance and adhesive cues to generate a favorable environment for axonal regrowth, 3) initiation of an inflammatory response to promote wound healing, and 4) proliferation to replace lost cells (Jessen et al., 2015) .
Furthermore, upon transection injuries that generate a gap in the nerve, dedifferentiated SCs guide regrowing axons through the nerve bridge, a piece of connective tissue that forms across the gap to rejoin the severed stumps (McDonald et al., 2006) . SCs from both stumps invade the bridge as multicellular cords and migrate directionally, eventually rejoining. This generates continuous cellular conduits across the wound and along which axons regrow to cross the gap and reinnervate the distal stump (Jessen et al., 2015; Parrinello et al., 2010) .
At the molecular level, cord migration is driven by Eph/ephrinmediated interactions between SCs and wound fibroblasts. Activation of EphB2 receptors on the SCs by ephrin-B ligands on fibroblasts induces SC sorting into cords through the relocalization of N-cadherin to cell-cell contacts in a Sox2-dependent manner .
Seminal work over the past few decades has uncovered key transcription factors (e.g., c-jun, sox2), epigenetic changes, and signaling pathways (e.g., ERK, Notch) that control SC reprogramming (Arthur-Farraj et al., 2012; Hung et al., 2015; Jessen et al., 2015; Le et al., 2005; Napoli et al., 2012; Woodhoo et al., 2009 ). However, a comprehensive molecular characterization of myelinating and dedifferentiated SCs in vivo is still lacking. Furthermore, despite the specialized function of bridge SCs, it remains unclear whether the reprogrammed state is homogeneous throughout the injured nerve or whether regional differences in SC state may exist, particularly within the bridge. This gap in our knowledge is largely due to the technical limitations of purifying sufficient numbers of SCs for standard downstream molecular analysis. Consistent with this, previous investigation of the transcriptional changes associated with nerve regeneration have been limited to analysis of whole nerves before and after injury (Arthur-Farraj et al., 2012; Jiang et al., 2014; Kubo et al., 2002; Le et al., 2005) . However, interpretation of this type of analysis is confounded by the cellular heterogeneity of nerve tissue, the pronounced inflammatory response that ensues injury, and the difference in SC content between intact and injured nerves (Cattin et al., 2015; Jessen et al., 2015) . Furthermore, whole-tissue approaches are not amenable to the analysis of bridge SCs due to the extensive influx of stromal and inflammatory cells into the nerve bridge. Nonetheless, deciphering the SC transcriptome and its modulation by the microenvironment is a prerequisite to the understanding of PNS regeneration and, more generally, of the molecular basis of somatic cell plasticity.
In this study, we developed a fluorescence-activated cell sorting (FACS)-based approach to prospectively purify SCs from mouse sciatic nerves. By combining this approach with RNA amplification protocols, we carried out transcriptional profiling of in vivo SCs from intact nerves and from bridge and distal stumps of transected nerves. Our analysis reveals novel phenotypes associated with SC reprogramming. Importantly, we also find that bridge SCs are a distinct subpopulation of progenitorlike SCs of increased mesenchymal character. We show that a localized increase in TGFb signaling in the bridge underlies this change in order to promote SC invasion into the wound. Surprisingly, our studies also reveal an unprecedented crosstalk between TGFb and EphB2, which we find is effected by transcriptional regulation of N-cadherin downstream of TGFb.
Together, our findings indicate that extracellular cues from the wound microenvironment intersect with cell-intrinsic dedifferentiation mechanisms to reprogram the SC to an invasive, mesenchymal-like cell. They further identify TGFb as a key mediator of peripheral nerve regeneration after transection and Eph/ephrin signaling as a novel TGFb effector, with important implications for the EMT, wound healing, and cancer.
RESULTS

Purification of Differentiated and Progenitor-like SCs
To isolate SCs from nerve tissue, we generated Schwann-cellspecific tdTomato reporter mice (hereafter tdTom SC ) by crossing P0A-Cre animals, which express Cre recombinase under the control of the neural crest-specific Myelin Protein Zero (Mpz) promoter, to Rosa26 tdTomato reporter strains (Giovannini et al., 2000; Madisen et al., 2010) . Consistent with previous studies, analysis of tdTom SC mice revealed strong tdTomato expression, unaffected by injury, in adult sciatic nerves ( Figures 1A and S1A ). Furthermore, coimmunostaining for the SC markers MBP and p75 NGFR , which specifically label myelinating and nonmyelinating SCs, respectively, confirmed that tdTomato recombination was efficient and restricted to SCs (Giovannini et al., 2000; Zheng et al., 2008) (Figures S1A and S1B). Thus, tdTomato is a suitable marker for purification of differentiated and dedifferentiated SCs from their in vivo microenvironment using FACS.
To this end, the right sciatic nerve of tdTom SC mice was transected and, 6 days later, the contralateral intact nerve and distal stump of the severed nerve were collected together with the nerve bridge to determine potential effects of the wound microenvironment. This time point was specifically chosen because it coincides with complete SC dedifferentiation and extensive, but not complete, invasion into the bridge ( Figure S2B ) (Chen et al., 2007; Parrinello et al., 2010) . Nerve tissue was dissociated to single cells, and SCs were sorted from other tdTomato À nerve cells based on tdTomato expression ( Figure 1B ). Single cell preparations from P0A-Cre À nerves were used as reference for setting FACS gates. Acute immunostaining and Calcein labeling of FACS-sorted tdTomato cells confirmed that tdTomato + cells were highly enriched for tdTomato expression, contained negligible contamination of tdTomato À cells, expressed the pan-SC marker S100b, and were viable (Figures S1C and S1D). FACS analysis of cell suspensions from all three nerve regions indicated that the vast majority of the tdTomato + but almost none of the tdTomato À cells were S100b + , further confirming the purity of sorted tdTomato cells ( Figure S1E ). Furthermore, qRT-PCR analysis indicated that tdTomato + cells from intact and transected nerves were enriched for the appropriate SC differentiation (Mpz, Plp, Pmp22) and dedifferentiation (p75 NGFR , (C) RNA-seq differential gene expression analysis of SCs from pooled distal stump (dSCs) and intact nerve (iSCs). Genes regulated over 2.53 (adj. p < 0.05, light blue), myelination genes (red circles), SC markers (black circles), and dedifferentiation markers (dark blue circles) are highlighted. (D) Functional analysis of genes differentially regulated between dSCs and iSCs. Genes with dSC:iSC count ratios >2.53 (adj. p < 0.05) were selected. -log 10 of the enrichment p values for selected GO categories (BP: biological process, CC: cellular components) are plotted relative to Z scores of average dSC:iSC count ratios in each category. Circle size denotes the number of regulated genes. (E) GSEA enrichment plots of dSCs compared to iSCs for the ''epithelial mesenchymal transition'' and ''Myc targets V1'' MSigDB hallmarks. (F) Average log 2 FPKM expression of the ES core, PRC, and Myc modules from for iSCs, pooled SCs isolated from the nerve bridge (bSCs), and dSCs, as well as differentiated cells of neural origin (Astrocytes, Neurons) and pluripotent ES cells (ES cells) (Zhang et al., 2014; Marks et al., 2012) . FPKM have been median centered to allow comparison across datasets. (G) GSEA enrichment analysis of dSCs compared to iSCs (D-I) and bSCs compared to iSCs (B-I) for MSigDB gene sets related to pluripotency (lines 2-10), regulation by the Prc2 complex (11-15), regulation by Myc (16-18), three ES modules (lines 1, 11, and 16), and markers of neural crest identity (19-21). Numbers represent normalized enrichment score and colors represent the FDR q values % 0.1 (red) or % 0.25 (orange/blue). See also Figure S1 .
Sox2, c-Jun) markers, respectively ( Figure S1F ). Therefore, our approach enables efficient purification of SCs from intact and severed nerve tissue.
We next characterized the in vivo SC transcriptome by highthoughput sequencing of cDNA (RNA-seq). Libraries were prepared from four biological replicates per nerve region using a Smart-seq2 based protocol, generating an average of $33 3 10 reads per sample and leading to quantification of $15,000 genes . Comparable transcriptome coverage was obtained from higher-RNA-input libraries derived from in vitro material, indicating that low RNA inputs did not compromise the sensitivity of our analysis (Table S1 ). Moreover, reproducibility of transcript level quantification between biological repeats was high, and PCA analysis separated the samples into three clearly distinct groups, which corresponded to nerve region of origin (Figures S1G and S1H).
Having confirmed the quality and reproducibility of the RNAseq data, we first examined the transcriptional changes that accompany dedifferentiation by comparing the transcriptomes of SCs isolated from intact nerve (iSCs) and distal stump (dSCs) ( Tables S2 and S3 ). Importantly, analysis of RNA spikein controls was not supportive of a global relative increase in RNA polymerase II (RNAPII) transcription levels upon dedifferentiation ( Figure S1I ). Instead, differential expression analysis indicated that a relatively small proportion of the SC transcriptome changed significantly (1,692 genes; 1,115 with >2.5-fold change). This entailed similar numbers of up-and downregulated genes that included well-established markers for both populations, further corroborating the validity of our method (Figure 1C) . Gene ontology (GO) and gene set enrichment analysis (GSEA) revealed several distinct biological features between differentiated and progenitor-like SCs. As expected, the transcriptome of dSCs was enriched for genes involved in cell cycle, immune recruitment, and phagocytosis, whereas GO terms associated with myelination and nerve conduction were significantly downregulated (Chen et al., 2007; Jessen et al., 2015) ( Figure 1D ). Moreover, our analysis revealed a switch in how SCs communicate with the surrounding nerve tissue, in that iSCs showed increased levels of cell-cell communication genes (cell junction), whereas dSCs favored expression of genes mediating communication with the extracellular matrix (extracellular signal and extracellular matrix). Notably, signatures of epithelial-to-mesenchymal transition (EMT) and activated Myc were among the most highly enriched GSEA gene sets in dSCs ( Figure 1E ).
The EMT has been linked to both somatic cell dedifferentiation to cancer stem cells and somatic cell reprogramming to induced pluripotent cells (iPS) (Ye and Weinberg, 2015) . The transcription factor Myc is a crucial regulator of ES pluripotency and one of the original Yamanaka reprogramming factors (Takahashi and Yamanaka, 2016) . Therefore, these signatures support the notion that dedifferentiation is a reprogramming event that converts SCs to progenitor-like cells (Arthur-Farraj et al., 2012) . To investigate this further, we analyzed expression of the three transcriptional programs that define ES cell pluripotency . These comprise targets of core pluripotency factors (i.e., Sox2, Nanog, Oct4, Core module), polycomb-related factors, which repress lineage-specific genes (PRC module), and Myc target genes (Myc module). Publicly available RNA-seq datasets of ES cells and differentiated CNS cells (astrocytes and neurons) served as reference transcriptomes Zhang et al., 2014) ( Figure 1F ). Remarkably, we found that dSCs activate Core and Myc modules while repressing the PRC module, a behavior reminiscent of ES cells . In contrast, module activity patterns of iSCs were similar to those of differentiated cells. Consistent with these results, GSEA analysis indicated that signatures of ES cells were highly enriched in dSCs ( Figure 1G ) (Ben-Porath et al., 2008; Bhattacharya et al., 2004; Kim et al., 2010; M€ uller et al., 2008; Wong et al., 2008) , whereas signatures of the neural crest, from which the SCs derive, were not (Simõ es-Costa et al., 2014) . These results suggest that, although lineage characteristics are retained after injury, dedifferentiation is not a reversal of the SC developmental program. Rather, injury reprograms SCs to a stem-like state.
Distal and Bridge SCs have Distinct Molecular Features
We next compared the transcriptomes of dSCs and bridge SCs (bSCs) ( Tables S2 and S3 ). Interestingly, the number of differentially expressed genes between bSCs and dSCs, despite both of these being in a dedifferentiated state, was comparable to the number detected between iSCs and dSCs (2,021 genes; 1,169 with >2.5-fold change), with an overall bias toward downregulation in the bridge ( Figure S2A ). We generated seven gene clusters by K-means clustering of expression ratios that were further examined by GO analysis and combined with GSEA analysis of the entire dataset (Figures 2A and 2B ; Table S4 ). Our analysis revealed a downregulation in genes essential to the repair program in bSCs, such as genes involved in inflammation, immune signaling, and ECM production, and a decrease in transcriptional activity. In contrast, genes involved in cell division, growth, and metabolism were strongly upregulated, suggesting that bridge cells might have an increased proliferative capacity. To test this more directly, we measured cell proliferation in vivo by pulsing tdTom SC mice with EdU for 4 hr from 4 to 10 days post-transection, a timeline encompassing all stages of SC migration into the bridge ( Figure S2B ). Consistent with the RNA-seq data, more EdU + SCs were detected in the bridge than in distal stump at all time points ( Figures 2C and 2D ), indicating that bSCs are more proliferative than their distal counterparts.
GSEA analysis indicated that the EMT and active Myc signatures detected upon transition from iSCs to dSCs were further enriched in bSCs, indicative of a potential change in differentiation state ( Figure 2B ). Indeed, closer examination of the bridge EMT signature revealed that bSCs had a more pronounced mesenchymal signature than did dSCs, with many EMT genes being more highly expressed in bSCs than in dSCs ( Figure 2E ). Of note, a similar decrease in Cdh1 expression, a hallmark of the EMT, was detected in both dSCs and bSCs (dSCs/iSCs: À5.13, p = 1.52e À6 ; bSCs/iSCs: À3.33, p = 2.5e À3 ). To further assess these differences and determine whether they are distinctive properties of bSCs throughout repair, we carried out time-course analysis of bSC and dSC transcriptomes by RNAseq (Table S6 ). SCs were acutely FACS-sorted from the bridge and distal stumps of single transected or contralateral intact nerves. dSCs were analyzed at days 1, 2, 4, 6, 8, and 10; nerve-matched bSCs were analyzed from day 4, the earliest time point at which invasion into the bridge occurs, up to day 10 ( Figure S2B ). Importantly, this analysis revealed that the differences in gene expression between bSCs and dSCs observed at day 6 are established as soon as bSCs enter the bridge and are maintained over time (Figures 2F and 2G) . Similarly, genes associated with repair (k-means clusters 1 and 7) were downregulated in bSCs at all time points ( Figures S2C and S2D) . In contrast, the increase in EMT genes was restricted to time points at which bSCs invade into the bridge, in that this increase began at day 4, peaked at day 6, and subsided at day 8, when invasion is largely complete ( Figures 2H and S2B ). Importantly, this enhanced EMT signature was never detected in dSCs, indicating that it is a bridge-specific phenotype ( Figure 2H ). Together, these results indicate that bridge SCs are a molecularly distinct subpopulation of dedifferentiated cells with reduced repair-promoting ability and with increased proliferation and differentiation toward the mesenchymal lineage.
TGFb Signaling Reprograms Bridge SCs to Invasive Mesenchymal-like Cells
The ECM and cellular composition of the bridge microenvironment is markedly different from the rest of the injured nerve (Cattin et al., 2015; McDonald et al., 2006; Parrinello et al., 2010) . We therefore hypothesized that wound-specific extracellular signals might underlie the distinct molecular profile of bSCs. TGFb is a particularly good candidate for this because it is a master regulator of the EMT and wound healing and has been previously linked to PNS regeneration (D'Antonio et al., 2006; Lamouille et al., 2014; reviewed in Mirsky et al., 2008) . We therefore examined TGFb activity in the regenerating nerve using two approaches. First, we coimmunostained wild-type nerves 6 days after cut for phosphorylated Smad3 (p-Smad3), the canonical downstream effector of the TGFb pathway (Shi and Massagué , 2003) , and also S100b, which labels all SCs in the injured nerve ( Figure S1E ). Consistent with previous reports of increased TGFb levels upon injury, p-smad3 + /S100b + cells could be detected throughout the cut nerve, but their number strongly increased in the bridge, indicating that TGFb signaling activity is maximal in bSCs (Figures 3A and 3B) (Mirsky et al., 2008) . Similar results were obtained in tdTom SC nerves ( Figure S3A ). Second, we interrogated the in vivo SC transcriptome for signatures of active TGFb signaling. To generate Schwann-cell-specific TGFb signatures, we performed RNA-seq of in vitro rat SCs that were cultured in the presence or absence of recombinant TGFb for 16 hr. Transcripts differentially expressed in response to TGFb treatment were used as signature gene sets for GSEA analysis of the in vivo datasets (Table S5 ). As shown in Figure 3C , we found that the Schwann-cell-specific TGFb signatures were enriched significantly in bSCs, but not in iSCs or dSCs. To further assess TGFb activity throughout the formation and invasion of bSC cords, we next examined TGFb signature genes in the RNA-seq time course data. We found that TGFb target gene expression is increased in bSCs relative to dSCs at all time points, confirming that TGFb signaling is highest in invading bSCs within regenerating cut nerves ( Figure 3D ). Consistent with these findings, TGFb mRNA levels were highly enriched in the bridge microenvironment; this was judged by qRT-PCR analysis of acutely FACSsorted tdTomato À bridge cells compared to tdTomato + SCs ( Figure S3B ). Furthermore, the bridge contained large numbers of p-Smad3 + /S100b À cells-many of which were fibroblasts and endothelial cells, the most abundant cell types in this region-and fibroblasts expressed higher levels of TGFb than SCs in vitro (Figures S3C-S3E) (Cattin et al., 2015; Parrinello et al., 2010) .
To understand the functional role of TGFb signaling in the bridge, genes that were commonly upregulated in both bSCs and TGFb-treated rat SCs were compared to GSEA Hallmark gene sets. This identified the EMT signature as the most significantly enriched gene set (p = 5.86e À15 ), indicating that TGFb may be primarily involved in driving the increased mesenchymal transition of bSCs. In agreement with this, qRT-PCR analysis confirmed that many bSC-specific EMT genes were TGFb targets ( Figure S4A ).
Next, we assessed the effects of loss of TGFb function in bSCs. We ablated TGFb receptor (TGFR) activity specifically in SCs by crossing the P0A-Cre strain to mice carrying conditional Tgfbr2 alleles, which encode for the obligatory component of the TGFb receptor complex TGFb receptor 2 protein (hereafter referred to as Tgfbr2 DSC ) (Levé en et al., 2002) . Genomic recombination of the Tgfbr2-floxed alleles in the adult sciatic nerves of Tgfbr2 DSC mice was confirmed by PCR analysis ( Figure S4B ). To assess recombination efficiency and functional inactivation of the pathway, Tgfbr2 fl/fl and Tgfbr2 DSC nerves were immunostained for p-smad3 and S100b, as in Figure 3 . This showed efficient, but variable, SC-specific loss of TGFR activity (60% to 80% of all SCs), consistent with previous studies (Figures S4C and S4D) (Giovannini et al., 2000; Zheng et al., 2008) . Importantly, ultrastructural analysis by electron microscopy of intact Tgfr2 DSC adult sciatic nerves revealed that they were similar to controls, indicating that this model can be used to study PNS regeneration in the absence of confounding developmental defects ( Figures S4E-S4G ).
Six days following transection, Tgfbr2 DSC and P0A-Cre À Tgfbr2 fl/fl control nerve bridges were immunostained for S100b, and SC regrowth from the proximal stump was examined by quantifying the average SC cord length and maximal migrated distance into the bridge. This revealed a marked defect in bridge regeneration in Tgfbr2 DSC compared to controls ( Figure 4A ). In control nerves, numerous parallel SC cords invaded and migrated robustly into the bridge, as expected (McDonald et al., 2006; Parrinello et al., 2010) . In contrast, in Tgfbr2 DSC mice, SC invasion was uneven and severely stunted, with cells extending much shorter distances from the proximal stump (Figures 4B and 4C) . To determine whether this phenotype depended on loss of TGFb-induced mesenchymal traits, we crossed Tgfbr2 DSC to tdTomato reporter mice, FACS-sorted bSCs from day-6 cut nerves of the resulting tdTom;Tgfbr2 DSC and littermate controls, and measured expression of bSCsspecific EMT genes by qRT-PCR. We found that the EMT signature was significantly downregulated in bSCs, but not in dSCs of Tgfbr2 DSC (Figures 4D, S4J, and S4K ). In addition, we carried out Boyden chamber assays and found that TGFb treatment significantly increases the ability of cultured rat and Tgfbr2 fl/fl mouse SCs to invade through fibronectin, a major component of the bridge ECM ( Figure 4E ) (Cattin et al., 2015) . In contrast, although SCs themselves produce TGFb ( Figure S3E ), neither pharmacological inhibition of TGFR in rat cells using two highly selective inhibitors (Akhurst and Hata, 2012) nor genetic deletion of Tgfbr2 in mouse SCs that were freshly isolated from Tgfbr2 fl/fl mice affected invasion (Figures 4F, S4H, and S4I ). Together, these results indicate that basal TGFR signaling is dispensable for sustaining the invasive ability of SCs. Rather, activation of TGBR by extrinsic TGFb in the bridge enhances SC invasiveness.
TGFb was shown to drive proliferation of cultured SCs in the presence of Neuregulin-1, a key SC mitogen (Parkinson et al., 2001) . This raised the possibility that wound TGFb might also be responsible for the increased proliferation of bSCs. We therefore measured EdU incorporation in bSCs of tdTom;Tgfbr2 DSC and control mice. As shown in Figure 4G , we found no significant difference in the number of EdU + /tdTomato + bSCs, indicating that TGFb does not regulate SC proliferation within the bridge. Consistent with this, TGFb treatment of SCs cultured in serum, a condition that mimics the wound environment, did not significantly affect their proliferation ( Figure 4H ). We conclude that TGFb induces a specialized mesenchymal transition in bSCs to increase their invasiveness, whereas bSCs proliferation is TGFb independent.
TGFb Potentiates and Enables Eph-Dependent SC Sorting
While analyzing the regenerating nerve bridge of Tgfr2 DSC , we noticed that SC cord migration into the bridge was highly disorganized. As regrowing axons comigrate with SCs from the proximal stump, we examined whether this aberrant SC migratory pattern also affected axons (Cattin et al., 2015; McDonald et al., 2006; Parrinello et al., 2010) . Immunostaining for axonal markers revealed that whereas in control mice axonal regrowth into the bridge was directed toward the distal stump, regrowing Tgfbr2 DSC axons were disordered and misdirected. Indeed, quantification of the angles of axonal regrowth relative to the long axis of the nerve showed a marked increase in the percentage of axons that grew at >45 angles in Tgfbr2 DSC compared to (D) qRT-PCR analysis of the bridge-specific mesenchymal gene signature in bSCs and dSCs FACS-sorted from single nerves of tdTom;Tgfbr2 fl/fl and tdTom;Tgfbr2 DSC mice. Boxplots represent log 2 bSC:dSC expression ratios of 24 bridge-specific EMT genes. Pooled data for Tgfrb2 fl/fl (blue bar, n = 6) and Tgfbr2 DSC (purple bar, n = 5) mice are shown; p Wilcoxon = 0.00024. The whiskers extend to the most extreme data point, which is no more than 1.53 the interquartile range from the box. (E) SC invasion through fibronectin-coated Boyden chambers in the absence or presence of TGFb. Rat SCs (rSC, solid bars) and mouse SCs (mSC, hatched bars) were treated with vehicle (blue bar) or TGFb (purple bar, 10 ng/mL) (mean ± SEM). n = 3, *p < 0.05, ***p < 0.001, one-way ANOVA. (F) SC invasion through fibronectin-coated Boyden chambers upon inhibition of TGFR signaling. Rat SCs (rSC) were left untreated or treated with TGFR inhibitors LY2157299 (LY; purple hatched bar) or SD208 (SD; purple spotted bar) for 24 hr prior to the assay. Mouse SCs (mSC) were either wild-type (Tgfbr2 fl/fl , blue vertical lines) or knockout (Tgfbr2 À/À ; purple vertical lines) (mean ± SEM). n = 3. (G) EdU incorporation in the bridges of tdTom;Tgfbr2 fl/fl (blue bar, n = 5) and tdTom;Tgfbr2 DSC (purple bar, n = 4) mice 6 days post-transection. EdU incorporation in tdTom;Tgfbr2 DSC is normalized to controls (mean ± SEM). (H) EdU incorporation in rat SCs treated with vehicle (Control, blue bar) or TGFb (TGFb, purple bar) for 16 hr in vitro (mean ± SEM). n = 3, p = 0.14, two-tailed paired Student's t test. Figures 4I and 4J) . The defect in SC and axonal migration into the bridge observed in Tgfbr2 DSC mice resulted in a significant decrease in reinnervation of the distal stump at 6 weeks post-transection ( Figures 4K and 4L ). However, no significant differences in the number or remyelination of distal axons were detected by electron microscopy at 3 months, suggesting that compensatory mechanisms enable long-term regeneration (data not shown).
This phenotype is remarkably similar to the regeneration defect of EphB2 knockout mice, raising the interesting possibility that the two pathways might interact in vivo . We previously reported that treatment of cultured SCs with recombinant ephrin-B2 ligands recapitulates their in vivo cell sorting behavior in response to bridge fibroblasts, resulting in the grouping of SCs into defined clusters . We therefore used this assay to examine effects of TGFb on EphB2-mediated SC sorting. SCs were cultured on control Fc or ephrin-B2-Fc proteins in the presence or absence of TGFb for 16 hr, and clustering was scored following immunostaining for S100b. Surprisingly, we found that TGFb induced mild clustering on its own and significantly enhanced cell sorting in response to ephrin-B2, leading to larger and more compact clusters ( Figures 5A and 5B ). Furthermore, we examined the effects of loss of TGFb activity on ephrin-B2-induced cell sorting in rat SCs cultured in the presence or absence of TGFR inhibitors and in freshly isolated Tgfbr2 À/À and Tgfbr2 fl/fl mouse cells. In both experiments, cell sorting was impaired ( Figures 5C and  5D) , indicating that EphB2 is strictly dependent on TGFb signaling for function. These effects were mediated by Smaddependent transcription downstream of TGFR because siRNA to the Co-Smad Smad4, which is required for nuclear translocation and transcriptional activity of p-Smads and which specifically inactivated TGFb signaling in our system ( Figure S5A) , also severely disrupted SC clustering in response to ephrin-B2 ( Figures 5E and 5F ) (Shi and Massagué , 2003) . Efficiency and specificity of the knockdown were confirmed by western blot analysis and parallel cell-sorting experiments, respectively, using a second independent siRNA oligo ( Figures S5B, S5C, 6B , and 6I). Thus, TGFb potentiates EphB2-dependent cell sorting, and its absence abolishes EphB2 function.
N-Cadherin Mediates TGFb/Eph Crosstalk
We next determined the mechanisms by which TGFb modulates the EphB2 pathway. On activation by ephrin-B ligands, EphB2 becomes phosphorylated (p-EphB2) and induces cell sorting by post-translationally modifying and stabilizing the pluripotency factor Sox2, which, in turn, increases Schwann cell-cell adhesion via relocalization of N-cadherin to cell-cell contacts . We therefore asked whether TGFb directly modulates any of these pathway components. Western blot analysis indicated that EphB2 phosphorylation was largely unaffected by either TGFb treatment or Smad4 knockdown ( Figures  6A-6C) . Of note, a small increase in phosphorylation levels was detected in TGFb samples. However, it was not accompanied by EphB2 internalization, a hallmark of activation, indicating that it did not elicit significant signaling (Figures 6A and 6B) . Similarly, whereas ephrin-B2 stimulation increased Sox2 levels as expected , TGFb treatment did not (Figure S6) . In contrast, analysis of N-cadherin in cell-sorting assays revealed marked regulation by TGFb. TGFb alone relocalized N-cadherin to Schwann cell-cell contacts to a similar extent as ephrin-B2 ligands alone, and the two ligands combined synergised to potentiate this effect ( Figures 6D and 6E) . Conversely, treatment with TGFR inhibitors or Smad4 knockdown abrogated the ability of ephrin-B2 to redistribute N-cadherin ( Figures 6F and  6G ). This was paralleled by changes in N-cadherin protein levels; TGFb increased N-cadherin levels, whereas Smad4 knockdown and inhibitor treatment strongly reduced basal N-cadherin levels, depleting both soluble and actin-bound N-cadherin pools (Figures 6H and 6I) . N-cadherin is a key EMT gene and a well-established TGFb target (Yang et al., 2015) . To test whether TGFb may regulate Cdh2, the N-cadherin encoding gene, at the transcriptional level, we performed qRT-PCR analysis. We found that whereas Cdh2 mRNA levels were unaffected by treatment with ephrin-B2 on its own, as expected, exposure to TGFb alone or with ephrin-B2 significantly increased Cdh2 expression. Inhibition of TGFb signaling had the opposite effect, reducing Cdh2 mRNA levels by about 50% (Figures 6J-6L) .
To functionally assess whether transcriptional regulation of N-cadherin mediates the TGFb/EphB2 crosstalk, we carried out gain-and loss-of-function cell sorting experiments. First, we knocked down Cdh2 using a concentration of siRNA oligos sufficient to block its increase in response to TGFb but insufficient to significantly alter Cdh2 basal levels and thus inhibit basal ephrin-B2-induced clustering ( Figure S7A ). This partial Cdh2 knockdown abolished clustering in TGFb samples and reduced cell sorting to the levels of ephrin-B2-treated samples in cells treated with both ligands (Figure 7A ). Then we ectopically increased Cdh2 expression by adenoviral transduction to a level similar to TGFb treatment (Ad-Cdh2 cells, Figure S7B ) and quantified cell sorting in the presence or absence of ephrin-B2 relative to GFP-transduced controls (Ad-Gfp cells). We found that untreated Ad-Cdh2 cells phenocopied TGFb-treated Ad-Gfp cultures and that treatment of Ad-Cdh2 cells with ephrin-B2 ligands closely mimicked the synergistic effects of TGFb and ephrin-B2 treatment combined ( Figure 7B ). Furthermore, increased Cdh2 levels fully rescued ephrin-B2-induced cell sorting in the presence of TGFR inhibitors ( Figure 7C ). Together, these results indicate that the increase in Cdh2 expression is both necessary and sufficient to potentiate cell sorting downstream of TGFb.
Finally, we examined the relevance of these findings to TGFb-mediated nerve regeneration in vivo. We first assessed effects of Tgfbr2 loss on SC cords in the bridge. We found a decrease in the number of SCs in cords and an increase in single cells indicative of impaired EphB2-mediated cell sorting ( Figures  7D and 7E ). Then we analyzed N-cadherin expression in vivo. Consistent with a bridge-specific function, N-cadherin levels were 1.96-fold higher in bSCs than in dSCs in our RNA-seq dataset ( Figure 7F ). In addition, qRT-PCR analysis indicated that, although variable due to the low RNA input and the variable recombination efficiency seen in the Tgfbr2 DSC mice, Cdh2 levels trended toward downregulation in Tgfbr2 DSC bSCs compared to Tgfbr2 fl/fl bSCs, but remained unchanged in dSCs (Figure 7G) . At the protein level, immunofluorescence analysis indicated that whereas N-cadherin was highly enriched at Schwann cell-cell contacts in the bridges of control nerves, the protein appeared mislocalized and more diffuse in Tgfbr2 DSC nerves ( Figure 7H) . This difference was not due to axonal Cdh2 expression; colocalization of neurofilament and N-cadherin proteins was minimal, and similar numbers of axonal fibers were seen in both genotypes ( Figure S7C ). Together, these observations confirm that N-cadherin is a TGFb effector within regenerating nerves in vivo.
DISCUSSION
Since the groundbreaking discovery that differentiated somatic cells can be induced to become pluripotent by overexpression of defined transcription factors, the molecular basis of experimental reprogramming has been the focus of intense investigation (Merrell and Stanger, 2016; Takahashi and Yamanaka, 2016) . However, increasing evidence suggests that, at least in some adult mammalian tissues, reprogramming can also occur naturally in response to injury (Merrell and Stanger, 2016) . One of the most striking examples of physiological reprogramming is the dedifferentiation of SCs that occurs in peripheral nerve regeneration (Jessen et al., 2015; Kim et al., 2013a) .
Here we developed a method to isolate pure populations of differentiated and dedifferentiated SCs from their in vivo nerve (legend on next page) microenvironment, enabling us to define the molecular profile of both states. This revealed several new features of SC reprogramming, including the acquisition of mesenchymal traits. The EMT has emerged as a hallmark of cell fate conversion in development, tumorigenesis and somatic cell reprogramming (Ye and Weinberg, 2015) . Our work indicates that natural reprogramming is also accompanied by passage through an EMT-like transition. This finding is further underscored by a recent study on leprosy (Masaki et al., 2013) , which demonstrated that the leprosy bacteria reprograms SCs to mesenchymal-like stem cells by downregulating lineage determinants and upregulating EMT genes. Consistent with previous reports, we found SC marker gene expression to be retained in injury-induced dedifferentiation. Indeed, our analyses showed that both bSCs and dSCs remain S100b + and express significant amounts of Sox10 mRNA (Figures S1E and S7D) (Chen et al., 2007; Jessen et al., 2015) . Interestingly, however, we found that Sox10 mRNA levels were reduced to similar extents in both dSCs and bSCs compared to iSCs ( Figure S7D ). Thus, a mesenchymal-like transition is likely not idiosyncratic to leprosy infection, but a physiological response to injury, which is exploited and augmented by the bacteria.
The identification of a partial mesenchymal transition provides important insights into the nature of SC dedifferentiation. Traditionally, dedifferentiation has been considered as a reversal to an earlier developmental stage in the SC lineage (Chen et al., 2007) . However, an important study recently challenged this view. The authors demonstrated that dedifferentiated SCs upregulate a specialized repair-promoting transcriptional program orchestrated by c-jun and suggested that injury reprograms cells to a ''repair cell'' (Arthur-Farraj et al., 2012) . Our analysis supports this idea and confirms that dedifferentiated SCs are more closely related to ES cells than their developmental progenitors, the neural crest. It also uncovers acquisition of mesenchymal traits as an additional molecular feature of the repair cell. Interestingly, the mesenchymal program was not altered in c-Jun knockout mice, suggesting that other EMT-specific transcription factors are likely involved (Arthur-Farraj et al., 2012) . Consistent with this idea, c-jun expression was not affected in bSCs and dSCs from Tgfbr2 DSC mice (data not shown), whereas the EMT factors Zeb1, Sox9, and HMGA2 were all upregulated in dedifferentiated SCs (Tables S2 and  S3 ) (Lamouille et al., 2014) .
The ability to carry out RNA-seq on minute numbers of cells purified from the in vivo nerve enabled us to compare the transcriptomes and ES modules of distal and bridge cells. We found that bSCs and dSCs are distinct cell populations with different transcriptomes and repair features, indicating that the microenvironment is a key regulator of the dedifferentiation program. Bridge cells switch off repair genes, increase expression of mesenchymal and Myc target genes, and proliferate more extensively than their distal counterparts. Intriguingly, this transcriptional profile is reminiscent of partially dedifferentiated cancer cells, suggesting that the wound microenvironment may promote a cancer-like phenotype Ye and Weinberg, 2015) . A link between wounding and cancer is well established in many tissues, including the PNS (Ribeiro et al., 2013; Zhu et al., 2016) . Our results reinforce this link and suggest that modulation of cell plasticity may be a key mechanism by which injury sensitizes normal cells to tumorigenesis. They might also explain recent findings that nerve injury induces neurofibroma formation selectively at the wound site in a mouse model of neurofibromatosis type 1 (Ribeiro et al., 2013) .
We identified TGFb as an important mediator of the bSC phenotype. Although TGFb signaling has been previously linked to the regulation of SC proliferation, apoptosis, and myelination, its role in nerve regeneration had not been previously assessed (D'Antonio et al., 2006; reviewed in Mirsky et al., 2008; Parkinson et al., 2001) . We showed that TGFb signaling is strongly increased across many cell types within the bridge and exploited our conditional, SC-specific Tgfbr2 knockout model to selectively study its role in bSCs. We found that TGFb exerts two highly interrelated and synergistic functions in PNS repair that are specific to bridge SCs: it reprograms bSCs to an invasive, mesenchymal-like cell type to drive invasion into the wound, and it concomitantly enhances EphB2-mediated cell sorting to promote directional collective migration. Together, these phenotypes drive repair through the hostile bridge microenvironment to enable peripheral nerve regeneration. However, consistent with a previous study, TGFb signaling was dispensable for bSC proliferation, indicating that signals other than TGFb are responsible (D'Antonio et al., 2006) . Our data suggest that TGFb is also not a key regulator of the increased Myc activity detected in the bridge. Indeed, although TGFb increased Myc expression in vitro, the overlap in differentially expressed Myc target genes between TGFb-treated SC and bSCs-specific genes was minimal (Tables S2 and S5 ). It will be important to identify the signals that drive proliferation and Myc within the wound in the future.
Whereas the ability of TGFb to induce a mesenchymal transition is well established, a crosstalk with Eph signaling has never been observed (Xu et al., 2009) . Remarkably, TGFb not only enhanced cell sorting downstream of EphB2 but was also necessary for EphB2 function. The crosstalk was mediated by the EphB2 effector N-cadherin, which we show is also a TGFb target. Overall, our mechanistic studies suggest a model whereby TGFb enhances Eph effects by maintaining high N-cadherin protein levels within bSCs. Upon activation by wound fibroblasts, Eph signaling relocalizes N-cadherin to cell-cell contacts, leading to robust SC sorting and directional migration. In contrast, in the absence of TGFb signaling, N-cadherin expression decreases to levels that are insufficient for Eph-mediated cell sorting, resulting in disorganized migration of the SCs and their accompanying axons.
In summary, our findings indicate that dedifferentiation is a multifaceted process controlled by the interplay of cell-intrinsic programs and cell-extrinsic signals. Following injury, neuronal degeneration relieves prodifferentiative axonal signals, thereby triggering SC dedifferentiation through activation of cell-intrinsic transcriptional programs. Extrinsic signals from the microenvironment then superimpose on these programs in a context-dependent manner to adapt SC function to the specific repair requirements of their surrounding tissue.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: cell TGFb signaling signatures were defined by DESseq2 analysis of RNA-seq data from rat Schwann cells treated in vitro with TGFb. Signatures include genes up or downregulated more than 2 fold with an adjusted p value < 0.0001 (Table S5) . The list of 200 genes form the HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION available on the GSEA website was used as EMT signature.
AUTHOR CONTRIBUTIONS
Conceptualization
Quantitative RT-PCR RNA was extracted from control Schwann cells or from Schwann cells treated overnight with 10ng/ml TGFb (R&D systems) using Trizol Reagent (Ambion). Frozen nerve samples were homogenized in Trizol Reagent using a TissueRuptor (QIAGEN). RNA was reverse transcribed using iScript gDNA clear cDNA synthesis kit (Bio-rad) and quantitative PCR was performed using the qPCRBIO SyGreen Mix Lo-Rox (PCR Biosystems). For quantitative RT-PCR from bridge and distal FACS-purified Schwann cells prepared from transected nerves of Tgfbr2 fl/fl or Tgrb2 DSC mice, cDNA libraries were prepared according to the Smart-Seq2 protocol. RNA input was 200pg for distal cells and 100pg for the bridge cells. Relative expression values for each gene of interest were obtained by normalizing to B2M and plotted in R.
In vivo quantifications
Quantifications of Schwann cell migration and axonal regrowth were carried out on fluorescent images acquired using inverted SPE confocal microscopes (Leica). 50 mm cryosections from Tgfbr2 fl/fl and Tgfbr2 DSC nerves were stained with S100b and/or neurofilament and DAPI and for each nerve, the same volume and number of z-stacks was taken and the same settings of acquisition were used. A projection of the z stacks was made and used for quantifications using Fiji software (http://fiji.sc/Fiji). For quantifications at 6 days post-transection, images of the 4 central sections of the bridge region of each nerve were taken and analyzed, as follows. A horizontal line was drawn demarcating the boundary between proximal stump and bridge, as assessed by DAPI staining and Schwann cell morphology. Lines perpendicular to this boundary were then drawn from the leading edge of each Schwann cord to the boundary itself across the entire width of the nerve. Cord length was then averaged in each mouse to calculate 'average cord length'. Maximum migrated distance was also measured as the longest cord in each animal. For quantification of axonal regrowth at 6 weeks post-transection, z stack images of distal stumps stained for neurofilament to identify axons were taken across the entire width of the nerve. Projections were converted to binary images and area occupied by axons was measured as a readout of reinnervation. 3 areas of identical size were measured along the entire length of the distal stump at regular intervals from the wound site and average axonal density calculated for each mouse. Quantifications of cell sorting were carried out in tdTom;Tgfbr2 fl/fl and tdTom;Tgfbr2 DSC mice to facilitate visualization of bridge Schwann cells. Images of the proximal bridge were taken across the four sections encompassing the central region of the nerve. Within each section, two areas of identical size were selected proximal to the leading edge of the Schwann cell cords and number of Schwann cells in cords in each area quantified and expressed as percentage of total number of cell per area.
Electron microscopy and morphological analyses
Sciatic nerves were collected and fixed in 2% (vol/vol) glutaraldehyde in 0.12M phosphate buffer, post-fixed in 2% osmium tetroxide overnight at 4C and in 2% Uranyl Acetate 45 min at 4C. Nerves were then dehydrated in an ethanol series before embedding in epoxy resin.
Semithin sections were cut with a glass knife at 0.1 mm, dried carefully and stained with 0.5% toluidine blue in 2% borax at 75 C for 30 s. After dehydration, sections were mounted with DPX (Sigma) and representative images were acquired using wide-field microscopy.
Ultrathin sections were cut with a diamond knife at 70 nm, collected onto formvar coated slot grids, stained with lead citrate and then visualized using transmission electron microscopy (T12 Tecnai Spirit, FEI) using a Morada camera and iTEM software (Olympus SIS). g ratios were determined by dividing the mean diameter of an axon without myelin by the mean diameter of the same axon with myelin. To determine the size distribution of myelinated fibers, axon diameter of 9 images (three 75.58x50.34 microns fields per mouse, 3 mice per genotype) were measured and binned based on their diameter. All measurements were acquired using Photoshop to draw the axons and their associated myelin sheath and Fiji software to measure their mean diameter.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using Prism (GraphPad Software). Fisher's exact test was used for the clustering experiments; Student's t test was used for paired data and ANOVA with Bonferroni correction for all group data. All experiments for which quantifications were performed were carried out a minimum of three times as indicated in the figure legends. Data are presented as mean ± SEM p < 0.05 was considered significant.
DATA AND SOFTWARE AVAILABILITY
Gene expression data are available in the Gene Expression Omnibus, GEO: GSE103039. Freely available software and algorithms used for analysis are listed in the resource table. Some unavailable analyses were specifically designed for the purpose of this paper using routines written in R R version 3.3.1 (https://www.r-project.org/). All custom scripts and data contained in this manuscript are available upon request from the Lead Contact.
